Mutual fund investments in the stock market are closely watched by retail investors because they invest in substantial quantities that can affect stock price changes. Furthermore, because ordinary investors find it difficult to get all important information about a company, they tend to follow the actions of institutional funds, notably mutual funds, to make investment decisions.
Here are three companies where Mutual Fund Holdings grew by up to 4.8% in Q1FY23-24 compared to Q4 FY 22-23.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes and probiotics.
Advanced Enzyme Technologies shares were trading at Rs 335.65 per share on Monday, up 2.02 percent from the previous close.
Mutual funds increased their stake in the company by 1.79 percent,i.e., from 5.29 percent in Q4FY 22-23 to 7.08 percent in Q1 FY 23-24. Domestic institutional investors hold 7.59 percent of the company as of the June quarter of fiscal year 23-24, while foreign investors hold 21.89 percent.
In the preceding six months, the Company’s stock grew by 19 percent, and in the last year, it has increased by 23 percent.
Company’s the net profit margin stands at 19.21 percent, and the operating margin at 27.16 percent.
Aether Industries Ltd
Aether Industries Ltd produces advanced intermediates and specialty chemicals such as Ortho Tolyl BenzoNitrile, N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.
Aether Industries shares were trading at Rs 1,080 per share on Monday, up 1.46 percent from the previous close.
Mutual funds increased their stake in the company by 4.89 percent,i.e., from 7.64 percent in Q4FY 22-23 to 12.53 percent in Q1 FY 23-24. The promoters hold 81.81 percent of the company as of the June quarter of fiscal year 23-24, while foreign investors hold 1.87 percent.
In the previous six months, the stock has increased by 21 percent, and in the last year, it has increased by 27 percent.
Company margins have improved over the years, the net profit margin of the company stands at 20.03 percent, and the operating margin at 27.58 percent.
Rossari Biotech Ltd
Rossari Biotech is a leading supplier of enzymes and specialty chemicals to the Textile, Paper, Pharma, Animal Health, and Construction Chemicals industries.
Rossari Biotech shares were trading at Rs 847.25 per share on Monday, down 1.10 percent from the previous close.
Mutual funds increased their stake in the company by 2.32 percent,i.e., from 13.08 percent in Q4FY 22-23 to 15.4 percent in Q1 FY 23-24. Domestic institutional investors hold 17.71 percent of the company as of the June quarter of fiscal year 23-24, while foreign investors hold 6.12 percent.
In the preceding six months, the Company’s stock grew by 24 percent, and it has grown by 16 percent year to date.
Company’s the net profit margin stands at 7.32 percent, and the operating margin at 10.28 percent.
Written by Omkar Chitnis
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
